Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.
AuteursQuiriny M, Rodrigues Vitόria J, Saiselet M, Dom G, De Saint Aubain N, Willemse E, Digonnet A, Dequanter D, Rodriguez A, Andry G, Detours V, Maenhaut C
Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.
AuteursQuiriny M, Rodrigues Vitόria J, Saiselet M, Dom G, De Saint Aubain N, Willemse E, Digonnet A, Dequanter D, Rodriguez A, Andry G, Detours V, Maenhaut C
Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.
AuteursQuiriny M, Rodrigues Vitόria J, Saiselet M, Dom G, De Saint Aubain N, Willemse E, Digonnet A, Dequanter D, Rodriguez A, Andry G, Detours V, Maenhaut C
Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.
AuteursQuiriny M, Rodrigues Vitόria J, Saiselet M, Dom G, De Saint Aubain N, Willemse E, Digonnet A, Dequanter D, Rodriguez A, Andry G, Detours V, Maenhaut C
Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.
AuteursQuiriny M, Rodrigues Vitόria J, Saiselet M, Dom G, De Saint Aubain N, Willemse E, Digonnet A, Dequanter D, Rodriguez A, Andry G, Detours V, Maenhaut C
Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.
AuteursId Boufker H, Lagneaux L, Najar M, Piccart M, Ghanem G, Body JJ, Journé F
Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.
AuteursId Boufker H, Lagneaux L, Najar M, Piccart M, Ghanem G, Body JJ, Journé F